Euretina Congress

LONDON — Technical improvements enabled by recent developments in small-incision 25-gauge vitrectomy have increased the functional outcomes and safety of traction retinal detachment surgery, according to a speaker here.

LONDON — The effects of cataract surgery on the posterior segment of the eye and the associated risks are often underestimated, according to a surgeon speaking at the Euretina meeting here.

LONDON — Gene therapy for Leber's congenital amaurosis is showing signs of success in an ongoing clinical trial, a physician said here.

LONDON — Diabetic macular edema with a tractional component that is not responding to anti-VEGF or laser therapy can be effectively treated with vitrectomy, according to a specialist.

LONDON — Head-to-head comparison of two anti-VEGFs showed virtually no difference between the drugs in safety and efficacy at 1 year, according to a speaker here.

LONDON — An implantable telescope has shown encouraging results in patients with end-stage age-related macular degeneration, a specialist said here.

LONDON — A dropped nucleus requires prompt intervention, expert hands and complete vitrectomy, according to a speaker here.

LONDON — Corneal refractive surgery causes a mild concussive injury to the eye that affects the vitreoretinal interface, according to a speaker at the Euretina meeting here.

LONDON — Results of a large study conducted at nine centers in England and the Republic of Ireland support internal limiting membrane peeling as the treatment of choice for patients with stage 2 or stage 3 full-thickness macular hole.

LONDON — Staining is mandatory for thorough, safe, easy internal limiting membrane removal, according to one speaker here.